Vistagen Therapeutics, Inc. (VTGN) Earnings Call Transcripts
About Vistagen Therapeutics, Inc.
Vistagen Therapeutics, Inc. (VTGN) is a publicly listed company in the Biotechnology industry, within the Health Care sector. It trades on NasdaqCM and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 19 calls on record spanning February 10, 2022 to June 30, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.
Earnings Call History
EarningsCalls.dev has 19 Vistagen Therapeutics, Inc. earnings call transcripts on record, spanning February 10, 2022 to June 30, 2026. Based on this history, Vistagen Therapeutics, Inc. reports quarterly. The most recent call on file is dated June 30, 2026. The full list is below — each row opens the complete, free-to-read transcript.
- Ticker
- VTGN
- Exchange
- NasdaqCM
- Country
- US
- Sector
- Health Care
- Industry
- Biotechnology
- Calls on record
- 19
- First call
- February 10, 2022
- Most recent
- June 30, 2026
- Reporting cadence
- quarterly
| Quarter | Date | |
|---|---|---|
| Special Calls | Jun 30, 2026 | Read transcript → |
| Q3 FY2026 | Feb 12, 2026 | Read transcript → |
| Q2 FY2026 | Nov 13, 2025 | Read transcript → |
| Q1 FY2026 | Aug 7, 2025 | Read transcript → |
| Earnings Calls | Jun 17, 2025 | Read transcript → |
| Q3 FY2025 | Feb 13, 2025 | Read transcript → |
| Q2 FY2025 | Nov 7, 2024 | Read transcript → |
| Q1 FY2025 | Aug 13, 2024 | Read transcript → |
| Q4 FY2024 | Jun 11, 2024 | Read transcript → |
| Q3 FY2024 | Feb 13, 2024 | Read transcript → |
| Q2 FY2024 | Nov 9, 2023 | Read transcript → |
| Q1 FY2024 | Aug 10, 2023 | Read transcript → |
| Earnings Calls | Jun 28, 2023 | Read transcript → |
| Q3 FY2023 | Feb 7, 2023 | Read transcript → |
| Q2 FY2023 | Nov 10, 2022 | Read transcript → |
| Company Conference Presentations | Sep 13, 2022 | Read transcript → |
| Q1 FY2023 | Aug 11, 2022 | Read transcript → |
| Earnings Calls | Jun 23, 2022 | Read transcript → |
| Q3 FY2022 | Feb 10, 2022 | Read transcript → |